Japanese Doctors Warn of Link Between COVID-19 and Thymoma-Associated Autoimmunity

Medical News: Japanese researchers have identified a significant new complication of COVID-19: thymoma-associated multiorgan autoimmunity (TAMA). The condition, typically linked to thymoma - a tumor of the thymus gland - presents symptoms that can resemble the severe and life-threatening graft-versus-host disease (GVHD). This discovery signals another potential risk in the aftermath of COVID-19 for individuals with a history of thymoma and related immune disorders.


Clinical picture at the time of the second biopsy. (a) Head with frontal-type alopecia and conspicuous desquamation. (b) Skin biopsy of the palm skin showing marked keratinization and desquamation. (c) Erythema of the lower extremities showing healing and desquamation. (d) Palm skin showing hyperkeratosis with parakeratosis and epidermal intercellular edema. Vacuolar degeneration of the epidermal-dermal border and lymphocytic infiltration into the epidermis were observed. Keratinization of numerous cells was observed in the epidermis. Lymphocytic infiltrate was found in the shallow dermis (hematoxylin–eosin [H-E] original magnification, ×200). (e) Scalp skin demonstrated epidermal and dermal findings similar to those of the palms. Marked lymphocytic infiltration in the follicular epithelium and keratinization of numerous cells were observed (H-E original magnification, ×200). (f) CD4 staining of the palm skin revealed sparse infiltration of CD4-positive T cells in the epidermis. (g) CD8 staining of the palm skin revealed marked intra-epidermal infiltration of CD8-positive T cells.

The research team, composed of experts from the Tokyo Medical University’s Departments of Dermatology, Neurology, and Surgery, identified this link in a 64-year-old woman who developed TAMA following a COVID-19 infection. The findings highlight a complex relationship between the immune system, thymoma, and the lingering effects of COVID-19. This Medical News report details their insights and concerns for the future as they uncover one more aspect of COVID-19’s impact.
 
Thymoma-Associated Multiorgan Autoimmunity (TAMA): A Closer Look
TAMA is a rare but severe condition often found in patients with a history of thymoma. This autoimmune disorder, unlike most, leads to symptoms across multiple organs, especially the skin, liver, and digestive tract. Although GVHD primarily affects organ transplant recipients, TAMA mimics this disease without any history of transplants. It results from a disruption in immune regulation, leading the body to attack its own tissues and organs.
 
In their groundbreaking study, the researchers investigated the case of a patient who experienced an autoimmune response after contracting COVID-19. This study represents the first documented instance of TAMA triggered by a COVID-19 infection, shedding light on how viral infections may worsen or even trigger autoimmune diseases in those already susceptible due to other health conditions.
 
A Case of COVID-19-Induced TAMA
The study’s subject was a Japanese woman with a history of myasthenia gravis and invasive thymoma, i nitially diagnosed over a decade ago. Despite extensive treatment, her thymoma returned repeatedly. Six days after her COVID-19 diagnosis, she began developing skin symptoms - small, scaly, and itchy red patches across her body, reminiscent of viral exanthema or drug reactions. When these symptoms spread to her limbs, she was prescribed topical steroids, yet the rash only worsened, expanding to cover her extremities.
 
Laboratory tests and biopsies revealed that the symptoms and immune markers were consistent with TAMA, an autoimmune response that shares several characteristics with GVHD. The physicians hypothesized that COVID-19 could have triggered this condition by disrupting regulatory T cell functions, leading to inflammatory and autoimmune responses within her body. She also developed gastrointestinal complications, further underscoring the systemic nature of this autoimmune response. Unfortunately, her condition deteriorated with a series of infections, including Candida fungemia and cytomegalovirus, which ultimately led to her passing three months later.
 
The Immune System and the COVID-19 Link
The thymus gland, located near the lungs, plays a crucial role in immune system development. A thymoma, or tumor of the thymus, can disrupt immune regulation by producing abnormal immune cells. This phenomenon creates an autoimmune-like condition similar to GVHD but occurs without the traditional trigger of bone marrow or organ transplantation. In TAMA, the body’s immune system misidentifies its own tissues as threats, leading to widespread organ damage.
 
The researchers observed that COVID-19 patients frequently exhibit a reduction in regulatory T cells, essential for suppressing immune responses. In individuals with thymoma, where immune regulation is already compromised, COVID-19 may lead to an immune overreaction, attacking multiple organs. This finding supports a growing body of evidence showing that SARS-CoV-2 can set off autoimmune responses by mimicking certain body proteins, confusing the immune system and causing it to attack its own cells and tissues.
 
Why COVID-19 May Trigger Autoimmune Reactions
Dr. Rie Hyobu, the lead author of the study, suggests that TAMA cases may increase among thymoma patients following COVID-19 infection. COVID-19 triggers a “cytokine storm,” where the body releases numerous inflammatory cytokines, such as interleukin-6 and tumor necrosis factor-alpha, which can exacerbate autoimmune reactions in vulnerable individuals. This immune system overload, in the presence of pre-existing immune disorders, might explain why COVID-19 led to TAMA in this case. In other cases, COVID-19 has been linked to autoimmune responses like rheumatoid arthritis, type 1 diabetes, and inflammatory bowel disease.
 
Additionally, COVID-19 is known to increase the likelihood of developing autoimmune diseases due to the viral components that mimic human proteins. When the immune system mounts an attack against SARS-CoV-2, it may inadvertently harm the body’s own cells, a process known as molecular mimicry. The researchers emphasize that the high level of CD8-positive T cells found in the affected organs resembles that of GVHD, providing further evidence of COVID-19’s potential to activate or worsen autoimmune disorders.
 
Potential Implications for Patients with Thymoma and Other Risk Factors
This case underscores the need for heightened awareness of autoimmune risks following COVID-19, especially among individuals with a history of immune-related conditions. Those with thymoma, like the study’s patient, may face an elevated risk of developing TAMA after contracting COVID-19. The Tokyo Medical University team suggests that other similar cases could arise, given the immune system’s complex response to COVID-19.
 
The researchers recommend that thymoma patients and others with compromised immune systems exercise caution to avoid COVID-19 exposure. If infected, these patients should be monitored closely for symptoms that could indicate autoimmune complications. This proactive approach could lead to early interventions, potentially minimizing severe outcomes.
 
Concluding Thoughts and Future Directions
This case report serves as a crucial reminder of the unforeseen impacts of COVID-19 on individuals with underlying health conditions. By establishing a direct link between COVID-19 and the onset of TAMA, the study opens doors for further investigation into the intersection between COVID-19 and autoimmune diseases. With this new understanding, doctors may be better equipped to recognize, diagnose, and treat autoimmune reactions triggered by COVID-19, particularly in patients with thymoma and other immune-compromising conditions.
 
As COVID-19 continues to evolve, so does our understanding of its long-term impacts. This case highlights the complexity of the virus and the importance of ongoing research into its varied effects. The researchers emphasize that more extensive studies are needed to identify possible preventive measures and treatments for TAMA and other COVID-19-induced autoimmune conditions.
 
The study findings were published in the peer-reviewed Journal of Dermatology.
https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17519
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/singapore-case-study-reveals-that-even-mild-covid-19-can-trigger-fatal-liver-failure-in-patients-with-autoimmune-liver-disease
 
https://www.thailandmedical.news/news/yale-study-finds-that-high-salt-intake-linked-to-multiple-sclerosis-and-autoimmune-diseases